Navigation Links
Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
Date:2/13/2008

PHOENIX, Feb. 13 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "Better Ways to Get Better(R)," will be presenting on Wednesday February 20, 2008, at the Roth Capital Partners 20th Annual OC Growth Stock Conference.

The Company will be presenting at 11:30 a.m. PT. To listen to the live presentation please visit http://www.matrixxinc.com. Interested parties should login 15 minutes prior to the event to register and to install Windows Media Player if necessary. A replay of the presentation will be archived at the same web site address for 30 days.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is engaged in the development, manufacture and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, produces, markets and sells Zicam(R) and Nasal Comfort(TM) products in the cough and cold category. The Company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Chewables(TM); Zicam Cold Remedy Oral Mist(TM); Zicam Cold Remedy RapidMelts(TM); Zicam Allergy Relief; Zicam Cold Remedy
'/>"/>

SOURCE Matrixx Initiatives, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
2. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
3. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
4. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. Cardiac Science to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
7. A Sneak Peek Into the Special Needs Home of Tomorrow - Renowned Autism Consultant Valerie Herskowitz to Present Latest Findings at Autism Through the Lifespan Conference February 14-17 in Orlando
8. Orqis(R) Medicals MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
9. Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
10. Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
11. Pet DRx to Present at Roth 20th Annual OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Medical ... with the prestigious 2013 Top-Rated Award by GreatNonprofits , ... “We are excited to be named a Top-Rated 2013 Nonprofit,” ... without the dedication of our over 3000 Volunteers and Staff ... especially significant as it came from those that have seen ...
(Date:5/21/2013)... Kan. Primary care practice transformation on a ... care reform efforts aimed at achieving better outcomes, ... emerging evidence that transformation toward the patient-centered medical ... health care environment, the U.S. Department of Health ... Quality funded 14 studies to learn more about ...
(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and the ... Community Wellness Fair to educate the public on health initiatives ... on Wednesday, May 22, 2013 from 4:00 pm until 7:00 ... Mallard Creek Road, Charlotte, NC 29262). , Medic, ... Mecklenburg County Department of Social Services are working ...
(Date:5/21/2013)... stent, which is a novel stent platform eluting ... the Xience Prime everolimus-eluting stent for the primary ... nine months in the results of an imaging ... BIOFLOW-II substudy used intravascular ultrasound (IVUS) and optical ... and stent apposition at nine months after treating ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The ... on cable networks and cable channels across the country, ... on its YouTube channel. The producers of the series ... in the shipping industry, the manufacturing industry, health-related companies, ... medical facilities and medical practitioners in all parts of ...
Breaking Medicine News(10 mins):Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2
... Minimally-Invasive Closed-Chest, Bypass Surgery; Created Robotic ... Emphasize Reproducibility of Procedure and Decrease Learning ... 28 Cardica, Inc.,(Nasdaq: CRDC ) ... M.D., is innovating robot-assisted,minimally-invasive cardiac bypass surgery ...
... May 28 /Xinhua-PRNewswire-FirstCall/ --,China Pharma Holdings, Inc. ... which develops, manufactures, and markets generic and ... it has entered,into a Securities Purchase Agreement ... accredited investors ("Investors") pursuant to which,China Pharma ...
... virus out of reach of drugs , , WEDNESDAY, May ... type of cell provides a "hideout" for HIV during drug ... These follicular dendritic cells (FDCs) are located throughout the body ... Brigham Young University and Johns Hopkins School of Medicine. , ...
... Fla., May 28 The Quantum Group,Inc. (Amex: ... of,business process solutions, service chain management, strategic consulting,and ... today that it is joining IBM,s Latin American ... a collection of human and computing,resources in North ...
... May 28 /PRNewswire-FirstCall/ - Innolife Pharma, Inc.,(Other OTC:INNP.PK ... to announce that,they have unveiled their new website. ... a much more comfortable feeling with regards to ... endeavors., About Innolife Pharma Inc., --------------------------, ...
... Response TV Leader Guthy-Renker Attracts yet Another Celebrity for ... America,s Best-Selling ... Guthy-Renker announced,today that Ryan Sheckler, famed skateboarder and television ... best-selling acne treatment,Proactiv Solution. Known for its wide range ...
Cached Medicine News:Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 2Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 3Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 4Health News:China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million 2Health News:China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million 3Health News:Scientists Break Into HIV 'Hideout' 2Health News:The Quantum Group & IBM Sign Research Collaboration Agreement for the LA Grid University Consortium 2Health News:The Quantum Group & IBM Sign Research Collaboration Agreement for the LA Grid University Consortium 3Health News:The Quantum Group & IBM Sign Research Collaboration Agreement for the LA Grid University Consortium 4Health News:Professional Skateboarder Ryan Sheckler to Become the Newest Face of Proactiv Solution 2Health News:Professional Skateboarder Ryan Sheckler to Become the Newest Face of Proactiv Solution 3
(Date:5/21/2013)... CINCINNATI , May 21, 2013  LCA-Vision Inc. (NASDAQ: ... correction services under the Lasik Plus ® brand, announces that ... to one-year terms at today,s annual meeting of stockholders.  These ... , co-founder and President of Bahl & Gaynor Investment Counsel ... with BSC Ventures , Edgar F. Heizer ...
(Date:5/21/2013)... , May 21, 2013  Decision Resources, ... advisory firms for pharmaceutical and healthcare issues, ... agent on key efficacy endpoints, including overall ... the most influence over surveyed U.S. and ... (HR-) positive, HER2-negative breast cancer. The two ...
(Date:5/21/2013)... 2013 Hurel Corporation ("Hurel"), a world-leading provider ... platforms, today announced the appointment of James ... Board of Directors. Dr. MacDonald is the former Executive ... Institute ("SPRI"), which was the pharmaceutical development arm of ... Co. in 2009. Over a career that ...
Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... ALCAT Test to help chronic symptoms such as obesity, ... Medical researchers from Dubai today reported in the April ... Medicine (The Effect of The ALCAT Test Diet Therapy ... unable to achieve goal weight loss by calorie restriction ...
... PAUL, Minn., April 3 Torax Medical Inc., a ... of gastroesophageal reflux disease (GERD) has commenced a pivotal ... The trial, which is being conducted at 15 leading ... Europe, will evaluate the safety and effectiveness of the ...
Cached Medicine Technology:Study Confirms: Your Hidden Food Allergies Are Making You Fat 2Study Confirms: Your Hidden Food Allergies Are Making You Fat 3Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: